MedPath

E-2511

Generic Name
E-2511

A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2021-12-07
Last Posted Date
2022-09-09
Lead Sponsor
Eisai Inc.
Target Recruit Count
47
Registration Number
NCT05147337
Locations
🇺🇸

California Clinical Trials Medical Group, Glendale, California, United States

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: E2511 Matched Placebo
First Posted Date
2020-09-14
Last Posted Date
2021-07-12
Lead Sponsor
Eisai Inc.
Target Recruit Count
45
Registration Number
NCT04547361
Locations
🇺🇸

Worldwide Clinical Trials, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath